Cargando…
IL-10 modified mRNA monotherapy prolongs survival after composite facial allografting through the induction of mixed chimerism
Vascularized composite allotransplantation has great potential in face transplantation by supporting functional restoration following tissue grafting. However, the need for lifelong administration of immunosuppressive drugs still limits its wide use. Modified mRNA (modRNA) technology provides an eff...
Autores principales: | Aviña, Ana Elena, De Paz, Dante, Huang, Shu-Chun, Chen, Kuan-Hung, Chang, Yun-Ching, Lee, Chin-Ming, Lin, Chia-Hsien, Wei, Fu-Chan, Wang, Aline Yen Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996371/ https://www.ncbi.nlm.nih.gov/pubmed/36910717 http://dx.doi.org/10.1016/j.omtn.2023.02.016 |
Ejemplares similares
-
The Mandible Ameliorates Facial Allograft Rejection and Is Associated with the Development of Regulatory T Cells and Mixed Chimerism
por: De Paz, Dante, et al.
Publicado: (2021) -
Donor-Specific Regulatory T Cells Acquired from Tolerant Mice Bearing Cardiac Allograft Promote Mixed Chimerism and Prolong Intestinal Allograft Survival
por: Shen, Xiao-Fei, et al.
Publicado: (2016) -
Prolonged Survival of Subcutaneous Allogeneic Islet Graft by Donor Chimerism without Immunosuppressive Treatment
por: Hsu, Brend Ray-Sea, et al.
Publicado: (2017) -
Anti-IL-6 eluting immunomodulatory biomaterials prolong skin allograft survival
por: Uehara, Mayuko, et al.
Publicado: (2019) -
Chimerism-Based Experimental Models for Tolerance Induction in Vascularized Composite Allografts: Cleveland Clinic Research Experience
por: Siemionow, Maria, et al.
Publicado: (2013)